| Product |
CAS |
Molecular formula |
More |
| Ethyl 4-((6-methoxypyridin-3-yl)methyl)quinoline-2-carboxylate |
1314141-50-8 |
C19H18N2O3 |
More |
| 5-(2-(4-Aminopiperidin-1-yl)thiazol-4-yl)-7-methyl-2,3-dihydro-1h-inde |
1314088-45-3 |
C18H23N3OS |
More |
| 2-(1-(4-Bromothiazol-2-yl)piperidin-4-ylamino)ethanol |
1314088-06-6 |
C10H16BrN3OS |
More |
| 4-(4-Hydroxybutylamino)azepane-1-carbothioamide |
1314088-05-5 |
C11H23N3OS |
More |
| 5-Chloro-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)isox |
1314087-76-7 |
C17H20ClNO |
More |
| 3-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)isoxazol-5(4h |
1314087-75-6 |
C17H21NO2 |
More |
| 1-(4-(1,1-Dimethyl-2,3-dihydro-1h-inden-5-yl)thiazol-2-yl)piperidin-4- |
1314085-43-2 |
C19H25N3S |
More |
| 5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carboxamidine |
1314077-25-2 |
C15H22N2 |
More |
| 5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carbothioamide |
1314077-24-1 |
C15H21NS |
More |
| 2-Bromo-1-(1,1-dimethyl-2,3-dihydro-1h-inden-5-yl)ethanone |
1314029-31-6 |
C13H15BrO |
More |
| 2-Bromo-1-(8-methyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone |
1314029-22-5 |
C13H15BrO |
More |
| 4-Bromo-5-(1-methyl-1h-pyrazol-4-yl)-1h-pyrrolo[2,3-b]pyridine |
1313021-73-6 |
C11H9BrN4 |
More |
| Isopropyl 2,6-dimethyl-4-oxocyclohexanecarboxylate |
1312678-21-9 |
C12H20O3 |
More |
| Methyl 4-hydroxy-2-methyl-4-(thiazol-2-yl)cyclohexanecarboxylate |
1312678-17-3 |
C12H17NO3S |
More |
| Ethyl 1-(4-(3-aminophenyl)thiazol-2-yl)piperidine-4-carboxylate |
1312573-01-5 |
C17H21N3O2S |
More |
| Ethyl 1-(4-(3-nitrophenyl)thiazol-2-yl)piperidine-4-carboxylate |
1312573-00-4 |
C17H19N3O4S |
More |
| 4-(5-Bromo-4-chlorothiazol-2-yl)-1,4-diazepan-2-one |
1312572-98-7 |
C8H9BrClN3OS |
More |
| 4-(4-Chlorothiazol-2-yl)-1,4-diazepan-2-one |
1312572-97-6 |
C8H10ClN3OS |
More |
| Ethyl 1-(5-(3-aminophenyl)thiazol-2-yl)piperidine-4-carboxylate |
1312572-86-3 |
C17H21N3O2S |
More |
| Ethyl 1-(5-(3-nitrophenyl)thiazol-2-yl)piperidine-4-carboxylate |
1312572-85-2 |
C17H19N3O4S |
More |
